quinazolines has been researched along with Seizures in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (30.23) | 18.7374 |
1990's | 3 (6.98) | 18.2507 |
2000's | 10 (23.26) | 29.6817 |
2010's | 16 (37.21) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Danzer, SC; Gross, C; MacLeod, MC; Tiwari, D; White, AR | 1 |
Amini, E; Faraj, FL; Gholami, K; Golpich, M; Rothan, HA; Teoh, TC; Yusof, R | 1 |
A Maklad, Y; Abuelizz, HA; Al-Salahi, R; Anouar, EH; Dib, RE; Marzouk, M; N Attia, H | 1 |
Ahn, JO; Chung, JY; Jaung, WJ; Jeon, KO; Ryu, MO; Song, WJ; Won, SH; Youn, HY | 1 |
Fujita, K; Kitami, Y; Miyama, S; Nagai, Y; Takei, H | 1 |
Madaiah, M; Prashanth, MK; Revanasiddappa, HD; Veeresh, B | 1 |
Abbas, Sel-S; Awadallah, FM; Ibrahim, NA; Kamel, G; Said, EG | 1 |
Bahare, RS; Khan, SA; Malik, S | 1 |
Deepakumari, HN; Jayanna, BK; Prashanth, MK; Revanasiddappa, HD; Veeresh, B | 1 |
Bari, SB; Ugale, VG | 1 |
Catarzi, D; Colotta, V; Filacchioni, G; Lenzi, O; Lingenhöhl, K; Ofner, S; Poli, D; Varano, F | 1 |
El-Azab, AS; Eltahir, KE | 2 |
Akazawa, Y; Imamura, F; Kumagai, T; Nishino, K; Okyuama, T; Uchida, J | 1 |
Bari, SB; Patel, HM; Shirkhedkar, AA; Surana, SJ; Ugale, VG; Wadodkar, SG | 1 |
Bian, M; Deng, XQ; Quan, ZS; Wang, SB; Zheng, Y | 1 |
Ali, I; Amir, M; Hassan, MZ | 1 |
Kumar, A; Srivastava, VK | 2 |
Buchan, AM; Chenard, BL; Critchett, DJ; Ganong, AH; Guanowsky, V; Menniti, FS; Seymour, PA; Welch, WM | 1 |
De Micheli, C; De Sarro, G; Ferreri, G; Grasso, S; Menniti, FS; Micale, N; Zappalà, M; Zuccalà, G | 1 |
Kingston, AE; Peters, SC; Shannon, HE | 1 |
De Sarro, G; Ferreri, G; Grasso, S; Micale, N; Postorino, G; Zappalà, M; Zuccalà, G | 1 |
Gabizon, A; Gipps, M; Grenader, T; Shavit, L | 1 |
Blanton, CD; Fatmi, AA; Iturrian, WB; Vaidya, NA | 1 |
Blanton, CD; Iturrian, WB; Kite, A; Panos, CH; Vaidya, NA | 1 |
Mohan Rao, VK; Prasad, CR; Sethi, U | 1 |
Chaudhari, A; Dwivedi, C; Misra, RS; Parmar, SS | 1 |
el-Feky, SA | 1 |
Hansen, HC; Jackson, HC; Judge, ME; Klitgaard, H; Kristiansen, M; Suzdak, PD; Swedberg, MD | 1 |
Ebert, U; Hönack, D; Löscher, W; Rundfeldt, C | 1 |
Scriba, GK; Usifoh, CO | 1 |
Chenard, BL; Critchett, D; DeVries, KM; Ewing, FE; Ganong, AH; Guanowsky, V; Guhan, S; Guinn, MR; Huang, J; Kelly, K; Lazzaro, J; Menniti, FS; Pagnozzi, MJ; Seymour, PA; Staigers, TL; Welch, WM | 1 |
Kardos, J; Kovács, R; Lasztóczi, B; Nyikos, L | 1 |
Baumann, N; Chermat, R; Lachapelle, F; Simon, P | 1 |
Brumleve, SJ; Chaturvedi, AK; Chaudhary, A; Parmar, SS | 1 |
Malhotra, CL; Mehta, VL | 1 |
Fryer, RI; Walser, A | 1 |
Ali, B; Gupta, TK; Kumar, R; Parmar, SS | 1 |
Combs, G; Diamond, L; Glasser, AC | 1 |
Chatterjee, BK; Dey, PK | 1 |
Bhaduri, AP; Gupta, CM; Khanna, NM | 1 |
Kobayashi, K; Mizuno, A; Mori, A; Mukawa, J; Okusu, H | 1 |
43 other study(ies) available for quinazolines and Seizures
Article | Year |
---|---|
PI3K isoform-selective inhibition in neuron-specific PTEN-deficient mice rescues molecular defects and reduces epilepsy-associated phenotypes.
Topics: Adenine; Animals; Cerebral Cortex; Class I Phosphatidylinositol 3-Kinases; Epilepsy; Female; Hippocampus; Male; Megalencephaly; Mice; Neurons; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Quinazolines; Seizures; Thiazoles | 2020 |
NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Hippocampus; Indoles; Male; Malondialdehyde; Molecular Docking Simulation; Protein Binding; Quinazolines; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures | 2017 |
Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Humans; Male; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Quinazolines; Seizures; Structure-Activity Relationship | 2017 |
Accidental afloqualone intoxication in two dogs.
Topics: Animals; Ataxia; Bradycardia; Dog Diseases; Dogs; Flumazenil; Male; Quinazolines; Respiratory Insufficiency; Seizures; Vomiting | 2018 |
Coma and seizure caused by an afloqualone overdose.
Topics: Child, Preschool; Coma; Drug Overdose; Female; Humans; Muscle Relaxants, Central; Quinazolines; Seizures | 2019 |
Synthesis, anticonvulsant, antioxidant and binding interaction of novel N-substituted methylquinazoline-2,4(1H,3H)-dione derivatives to bovine serum albumin: a structure-activity relationship study.
Topics: Animals; Anticonvulsants; Antioxidants; Binding Sites; Biphenyl Compounds; Cattle; Mice; Picrates; Protein Binding; Quinazolines; Seizures; Serum Albumin, Bovine; Spectrometry, Fluorescence; Structure-Activity Relationship; Superoxides | 2013 |
Design and synthesis of some 3-substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3H)-one derivatives as potential anticonvulsant agents.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Design; Female; Hydrazines; Lethal Dose 50; Male; Mice; Neurons; Pentylenetetrazole; Quinazolines; Quinazolinones; Seizures; Triazines | 2013 |
Design, synthesis and anticonvulsant evaluation of N-(benzo[d]thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide derivatives: a hybrid pharmacophore approach.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Disease Models, Animal; Drug Design; Electroshock; Injections, Intraperitoneal; Mice; Molecular Structure; Quinazolines; Rats; Rats, Wistar; Seizures; Thiazoles; Thioamides | 2013 |
Synthesis and Anticonvulsant Activity of N-(Substituted)-1-methyl-2,4-dioxo-1,2-dihydroquinazoline-3(4H)-carboxamides.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Methaqualone; Mice; Pentylenetetrazole; Picrotoxin; Quinazolines; Seizures; Structure-Activity Relationship; Valproic Acid | 2016 |
Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
Topics: Acetamides; Animals; Anticonvulsants; Computer Simulation; Dose-Response Relationship, Drug; Drug Design; Electroshock; Mice; Molecular Docking Simulation; Molecular Structure; Pentylenetetrazole; Quinazolines; Seizures; Structure-Activity Relationship | 2016 |
Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.
Topics: Animals; Anticonvulsants; Mice; Oocytes; Quinazolines; Quinoxalines; Rats; Receptors, AMPA; Seizures | 2010 |
Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives.
Topics: Animals; Anticonvulsants; Chemistry, Pharmaceutical; Drug Design; Humans; Male; Methaqualone; Mice; Models, Chemical; Nervous System; Quinazolines; Seizures; Valproic Acid | 2012 |
Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities.
Topics: Amines; Animals; Anticonvulsants; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasms; Quinazolines; Seizures | 2012 |
Subacute transient encephalopathy induced by erlotinib.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Central Nervous System Diseases; Confusion; Erlotinib Hydrochloride; Female; Humans; Irritable Mood; Lethargy; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Seizures; Unconsciousness; Urinary Incontinence | 2011 |
Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents.
Topics: Animals; Anticonvulsants; Benzothiazoles; Drug Design; Electroshock; Male; Mice; Pentylenetetrazole; Quinazolines; Seizures | 2012 |
Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.
Topics: Amines; Animals; Anticonvulsants; Drug Design; Electroshock; Mice; Mice, Inbred Strains; Molecular Structure; Neurotoxicity Syndromes; Quinazolines; Rotarod Performance Test; Seizures; Triazoles | 2013 |
Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Brain; Disease Models, Animal; Drug Design; gamma-Aminobutyric Acid; Mice; Molecular Structure; Quinazolines; Seizures; Structure-Activity Relationship; Swimming | 2013 |
Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4 3H-ones as potential anticonvulsant agents.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Pentobarbital; Quinazolines; Rats; Rats, Inbred Strains; Seizures; Sleep; Structure-Activity Relationship; Thiadiazoles | 2002 |
CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
Topics: Animals; Brain Ischemia; Hippocampus; Male; Motor Activity; Neuroprotective Agents; Pentylenetetrazole; Quinazolines; Rats; Receptors, AMPA; Seizures; Synaptic Transmission | 2003 |
1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Benzodiazepines; Drug Design; Mice; Models, Molecular; Quinazolines; Seizures; Structure-Activity Relationship | 2003 |
Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo/thiobarbituric acid as potent anticonvulsant agents.
Topics: Animals; Anticonvulsants; Conscious Sedation; Exploratory Behavior; Hypnosis; Motor Activity; Quinazolines; Rats; Seizures; Sleep; Thiobarbiturates | 2004 |
Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred DBA; Pentylenetetrazole; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Seizures; Sensory Thresholds; Time Factors | 2005 |
Synthesis of novel 3-(alkylcarbamoyl)-2-aryl-1,2-dihydro-6,7-(methylenedioxy)-3H-quinazolin-4-ones as anticonvulsant agents.
Topics: Animals; Anticonvulsants; Drugs, Investigational; Mice; Mice, Inbred DBA; Protein Binding; Quinazolines; Rats; Seizures | 2006 |
Significant drug interaction: phenytoin toxicity due to erlotinib.
Topics: Anticonvulsants; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Phenytoin; Protein Kinase Inhibitors; Quinazolines; Seizures | 2007 |
Synthesis of previously inaccessible quinazolines and 1,4-benzodiazepines as potential anticonvulsants.
Topics: Animals; Anticonvulsants; Benzodiazepines; Mice; Pentylenetetrazole; Quinazolines; Receptors, Cell Surface; Receptors, GABA-A; Seizures | 1984 |
Synthesis of 3,4-dihydro-4-oxoquinazoline derivatives as potential anticonvulsants.
Topics: Animals; Anticonvulsants; Drug Evaluation, Preclinical; Electroshock; Magnetic Resonance Spectroscopy; Male; Mice; Pentylenetetrazole; Quinazolines; Seizures; Spectrophotometry, Infrared; Structure-Activity Relationship | 1983 |
Drug interactions between centazolone & some centrally acting agents.
Topics: Amphetamine; Animals; Drug Interactions; Pentylenetetrazole; Quinazolines; Rats; Seizures; Strychnine; Tranquilizing Agents | 1981 |
Correlation between monoamine oxidase inhibitors and anticonvulsants.
Topics: Animals; Anticonvulsants; Male; Mice; Monoamine Oxidase Inhibitors; Quinazolines; Seizures; Structure-Activity Relationship | 1980 |
Synthesis and anticonvulsant properties of some novel quinazolinone thiazolidine and 4-thiazolidone derivatives.
Topics: Animals; Anticonvulsants; Female; Male; Mice; Pentylenetetrazole; Quinazolines; Seizures; Spectrophotometry, Infrared; Thiazoles | 1993 |
Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Topics: Acoustic Stimulation; Amygdala; Animals; Anticonvulsants; Bicuculline; Carbolines; Clonazepam; Diazepam; Electroshock; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Kindling, Neurologic; Male; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Pentylenetetrazole; Quinazolines; Rats; Rats, Wistar; Seizures | 1996 |
Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. II. The novel imidazoquinazolines NNC 14-0185 and NNC 14-0189.
Topics: Animals; Anticonvulsants; Body Temperature; Drug Tolerance; GABA-A Receptor Agonists; Male; Mice; Motor Activity; Quinazolines; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Synthesis and anticonvulsant activity of acetylenic quinazolinone derivatives.
Topics: Acetylene; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Ketones; Male; Mice; Quinazolines; Seizures | 2000 |
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
Topics: Animals; Anticonvulsants; Binding, Competitive; Brain; Calcium; Disease Models, Animal; Inhibitory Concentration 50; Isomerism; Neuromuscular Blocking Agents; Protein Binding; Pyridines; Quinazolines; Quinazolinones; Rats; Receptors, AMPA; Seizures; Solubility; Structure-Activity Relationship; Synaptic Transmission | 2001 |
A glutamate receptor subtype antagonist inhibits seizures in rat hippocampal slices.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anticonvulsants; Electrophysiology; Excitatory Amino Acid Antagonists; In Vitro Techniques; Magnesium; Male; Membrane Potentials; Piperidines; Quinazolines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Seizures | 2002 |
Anticonvulsant effect of yohimbine in quaking mice: antagonism by clonidine and prazosine.
Topics: Animals; Anticonvulsants; Clonidine; Male; Mice; Mice, Quaking; Phentolamine; Prazosin; Quinazolines; Seizures; Yohimbine | 1979 |
Substituted piperazinoquinazolones: relationship between selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations and anticonvulsant activity.
Topics: Animals; Anticonvulsants; Brain; Citrates; Hydroxybutyrates; In Vitro Techniques; Isocitrates; Ketoglutaric Acids; Male; NAD; ortho-Aminobenzoates; Oxidation-Reduction; Pentylenetetrazole; Piperazines; Pyruvates; Quinazolines; Rats; Seizures; Structure-Activity Relationship | 1974 |
Anticonvulsant and some neuropharmacological properties of 2-methyl-3-omicron-tolyl-6-chloro-4(3h)-quinazolone and related compounds.
Topics: Analgesics; Animals; Anticonvulsants; Behavior, Animal; Body Temperature; Central Nervous System; Drug Synergism; Electric Stimulation; Electrophysiology; Hypnotics and Sedatives; Mice; Pentylenetetrazole; Quinazolines; Rats; Seizures; Sleep | 1966 |
Quinazolines and 1,4-benzodiazepines. 69. 1-Vinyl-1,4-benzodiazepin-2-ones and 1-vinylquinazolin-2(1H)-ones.
Topics: Animals; Benzodiazepinones; Central Nervous System; Chlordiazepoxide; Depression, Chemical; Diazepam; Flurazepam; Lethal Dose 50; Mice; Pentylenetetrazole; Quinazolines; Seizures; Vinyl Compounds | 1974 |
Relationship between CNS depressant activity and selective enzyme inhibition by quinazolone salicylhydrazide derivatives.
Topics: Animals; Anticonvulsants; Brain; Drug Synergism; Electroconvulsive Therapy; Hydrazines; Hypnotics and Sedatives; In Vitro Techniques; Mice; Oxidation-Reduction; Oxidoreductases; Oxygen Consumption; Pentobarbital; Pentylenetetrazole; Pyruvates; Quinazolines; Salicylates; Seizures; Structure-Activity Relationship; Succinates | 1973 |
Synthesis and anticonvulsant activity of substituted 2-thioquinazolin-4-ones. I. Preliminary studies.
Topics: Animals; Anticonvulsants; Chemical Phenomena; Chemistry; Electroshock; Male; Mice; Pentylenetetrazole; Phenobarbital; Phenytoin; Quinazolines; Seizures | 1971 |
Effect of glycosine on the higher nervous activity.
Topics: Animals; Anticonvulsants; Blood Pressure; Cocaine; Depression, Chemical; Heart; Higher Nervous Activity; Mescaline; Mice; Muscle Contraction; Pentylenetetrazole; Quinazolines; Seizures; Strychnine; Thiopental | 1967 |
Drugs acting on the central nervous system. Syntheses of substituted quinazolones and quinazolines and triazepino- and triazocinoquinazolones.
Topics: Animals; Azepines; Central Nervous System; Chemical Phenomena; Chemistry, Physical; Depression, Chemical; Electroshock; Ketones; Mice; Quinazolines; Seizures; Stimulation, Chemical | 1968 |
[Metabolism and anti-convulsive action of 2-[beta-pyridyl-(2")-ethenyl]-3-(2'-methylphenyl)-quinazolinone-(4) (B169)].
Topics: Animals; Anticonvulsants; Brain; Cats; Cerebral Cortex; Electroencephalography; Feces; Female; Hippocampus; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Liver; Lung; Mice; Myocardium; Quinazolines; Rabbits; Seizures; Spleen; Tritium | 1969 |